Truist analyst Jailendra Singh raised the firm’s price target on Doximity (DOCS) to $49 from $35 and keeps a Hold rating on the shares. The firm is updating its model after the company’s Q2 earnings beat and above-consensus outlook, also raising its FY25 EBITDA view by $23M to $279M and its FY25 view by $32M to $311M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
- Doximity upgraded to Equal Weight from Underweight at Morgan Stanley
- Starbucks, Spotify downgraded: Wall Street’s top analyst calls
- Doximity downgraded to Hold from Buy at Canaccord
- Doximity price target raised to $75 from $52 at Barclays
- Nvidia trades on Dow for first time, Rivian reports downbeat Q3: Morning Buzz